448 related articles for article (PubMed ID: 1858971)
1. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
3. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
4. Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.
Drowart A; Chanteau S; Huygen K; De Cock M; Cartel JL; De Bruyn J; Launois P; Yernault JC; Van Vooren JP
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):29-34. PubMed ID: 8326178
[TBL] [Abstract][Full Text] [Related]
5. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens.
Cho SN; Cellona RV; Fajardo TT; Abalos RM; dela Cruz EC; Walsh GP; Kim JD; Brennan PJ
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):25-31. PubMed ID: 2030314
[TBL] [Abstract][Full Text] [Related]
6. Bacillaemia in leprosy and effect of multidrug therapy.
Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Ganguly NK
Lepr Rev; 1989 Sep; 60(3):197-201. PubMed ID: 2682105
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
Wabitsch KR; Meyers WM
Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
[No Abstract] [Full Text] [Related]
9. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy.
Cho SN; Cellona RV; Villahermosa LG; Fajardo TT; Balagon MV; Abalos RM; Tan EV; Walsh GP; Kim JD; Brennan PJ
Clin Diagn Lab Immunol; 2001 Jan; 8(1):138-42. PubMed ID: 11139208
[TBL] [Abstract][Full Text] [Related]
10. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Fu X; Liu H; Zhang F
Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
[No Abstract] [Full Text] [Related]
11. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
12. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
[TBL] [Abstract][Full Text] [Related]
13. Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses.
Roche PW; Britton WJ; Failbus SS; Williams D; Pradhan HM; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):480-90. PubMed ID: 2205683
[TBL] [Abstract][Full Text] [Related]
14. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
15. Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy.
Young DB; Harnisch JP; Knight J; Buchanan TM
J Infect Dis; 1985 Nov; 152(5):1078-81. PubMed ID: 3900237
[No Abstract] [Full Text] [Related]
16. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
[No Abstract] [Full Text] [Related]
17. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
18. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
Parkash O; Girdhar BK
Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
20. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M
Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
